跳至主要内容
临床试验/JPRN-jRCTs072180051
JPRN-jRCTs072180051暂停2 期

Study of effectiveness and safety on the hair loss restraint by scalpcooling with scalp cooling device in the breast cancer chemotherapy - Scalp cooling study

TOKUNAGA Eriko0 个研究点目标入组 21 人开始时间: 2019年3月15日最近更新:
适应症

试验速览

阶段
2 期
状态
暂停
发起方
入组人数
21

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20age 至 75age(—)
性别
Female

入选标准

  • 1)Histologically comfirmed primary breast cancer
  • 2)Stage I, II or III
  • 3)Female aged 20 to 75 years old
  • 4)The case for that is planned anthracycline, taxan-based chemotherapy and in that hair loss is expected
  • 5)No history of the chemotherapy for the malignant tumor
  • 6)Signed informed consent of the patient for registration

排除标准

  • 1)Chilly allergy
  • 2)Cold agglutinin disease
  • 3)Any scalp skin tumor
  • 4)History of radiation for head
  • 5)Temporomandibular disorder or disease to a chin
  • 6)Any other cases who are regarded as inadequate for study enrollment by the attending doctors

研究者

发起方
TOKUNAGA Eriko

相似试验